Herpes/CMV Word Scramble
|
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Question | Answer |
Herpes Simplex 1 & 2 | 1 - oral 2 - genital |
Varicella-Zoster | chicken pox, shingles |
Alpha herpes virus | HSV 1 & 2, VZV |
Beta herpes virus | CMV, HHV 6 & 7 (HH-human herpes virus) |
Gamma herpes virus | EBV (Epstein-Barr), HHV 8 |
CMV will cause | CMV retinitis, encephalitis in HIV, colitis, pneumonitis, CNS infection lead to organ disease; occur most in advanced immunosuppressed pts |
Anti-Herpes and anti-CMV agents inhibit what to stop infection? | DNA polymerase (copy viral DNA) |
Anti-Herpes Agents | acyclovir,valacyclovir, famciclovir, docosanol (abreva), penciclovir, trifluridine |
Acyclovir, penciclovir; ganciclovir (treat CMV) (anti herpes agent) | requires activation by 3 phosphorylation; 1st-viral thymidine kinase;competitive inhibition of viral DNA polymerase and inhibition of viral DNA synthesis=chain termination; 2.5-3hrs; excretion-kidneys; drink water to prevent nephrotoxicity;10x potent |
mutation of DNA polymerase (enzyme no longer inhibited by drug) and viral thymidine (drug is no longer activated) | resistance to anti-herpes agents |
Valacyclovir (anti herpes agent) | ester prodrug of acyclovir (greater absorption, 3-5x blood levels) |
Famciclovir (anti herpes agent) | active against all herpes except CMV, needs to activated, NVD/HA, good absorption |
Docosanol (abreva) (anti herpes agent) | 22 carbon alcohol, inhibits HSV fusion (entry) w/cell membrane; topical |
Penciclovir (anti herpes agent) | topical, active metabolite of famciclovir, excreted urine (kidneys) |
Trifluridine (anti herpes agent) | fluorinated pyrimidine nucleoside, need no activation |
Anti-CMV Agents | ganciclovir, valganciclovir, foscarnet, cidofovir; inhibit CMV (viral) DNA polymerase |
acyclovir,valacyclovir, famciclovir, docosanol (abreva), penciclovir, trifluridine | Anti-Herpes Agents |
ganciclovir, valganciclovir, foscarnet, cidofovir | Anti-CMV Agents |
Ganciclovir (anti-CMV agent) | need activation (phosphyloration) by CMV specific kinase, excreted renal, poor PO absorption, IV/intraocular implant (CMV retinitis); 4 hrs, cleared by dialysis, MYELOSUPPRESSION, neutropenia, NVD, rash, HA, altered liver enzymes, peripheral neuropathy |
Valganciclovir (anti-CMV agent) | ester prodrug of ganciclovir, take w/food, excreted renal, well absorbed, metabolized in liver and intestinal wall to be converted to ganciclovir, lost via dialysis |
Foscarnet (anti-CMV agent) | inhibits viral DNA/RNA polymerase and HIV RT WITHOUT phosphorylation (no activation)against wide-range of HSV 1 and 2, CMV, VZV, EBV; excreted renal, toxic, IV only, 3-7 hrs, poor PO absorption, NEPHROTOXICITY |
Foscarnet interactions/S&S (anti-CMV agent) | aminoglycosides:nephrotoxicity-NVD, anemia,altered ca+/phosphate levels,high urine concentrations, genital ulcerations, high liver enzymes impenem(beta lactam - carbapenems group)=seizures CNS toxicity: HA, hallucinations, seizures (impenem interaction) |
Cidofovir (anti-CMV agent) | potent inhibitor of viral DNA polymerase, broad spectrum(HSV,CMV),phosphorylated independent of viral kinases(not specific-bad);excreted renal,infused w/probenecid to prevent tubular secretion of cidofovir and nephrotoxicity; neutropenia, uveitis (uvea) |
prehydrate w/NS to prevent dose-dependent renal tubule toxicity | cidofovir (anti-CMV agent) |
Cidofovir (anti-CMV agent) | avoid with other nephrotoxicity meds: aminoglycosides, foscarnet, NSAIDS |
need no activation (phosphyloration) by viral kinase | foscarnet (HSV agent), cidofovir (CMV agent, trifluridine (HSV agent) |
inhibition of viral DNA polymerase | acyclovir,vidarabine,foscarnet,ganiciclovir |
esters | added to drug for better absorption than in the tissues |
Viral DNA polymerase | enzyme that makes copies of viral DNA (replication) |
Created by:
cburrows
Popular Pharmacology sets